<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1320f" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1320f/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1320f/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1320f"><akn:num>1320f</akn:num><akn:heading>Establishment of program</akn:heading><akn:content><akn:p>§ 1320f. Establishment of program(a) In generalThe Secretary shall establish a Drug Price Negotiation Program (in this part referred to as the “program”). Under the program, with respect to each price applicability period, the Secretary shall—(1) publish a list of selected drugs in accordance with section 1320f–1 of this title;

(2) enter into agreements with manufacturers of selected drugs with respect to such period, in accordance with section 1320f–2 of this title;

(3) negotiate and, if applicable, renegotiate maximum fair prices for such selected drugs, in accordance with section 1320f–3 of this title; 11 So in original. Probably should be followed by “and”.

(4) carry out the publication and administrative duties and compliance monitoring in accordance with sections 1320f–4 and 1320f–5 of this title.


(b) Definitions relating to timingFor purposes of this part:(1) Initial price applicability yearThe term “initial price applicability year” means a year (beginning with 2026).


(2) Price applicability periodThe term “price applicability period” means, with respect to a qualifying single source drug, the period beginning with the first initial price applicability year with respect to which such drug is a selected drug and ending with the last year during which the drug is a selected drug.


(3) Selected drug publication dateThe term “selected drug publication date” means, with respect to each initial price applicability year, February 1 of the year that begins 2 years prior to such year.


(4) Negotiation periodThe term “negotiation period” means, with respect to an initial price applicability year with respect to a selected drug, the period—(A) beginning on the sooner of—(i) the date on which the manufacturer of the drug and the Secretary enter into an agreement under section 1320f–2 of this title with respect to such drug; or

(ii) February 28 following the selected drug publication date with respect to such selected drug; and


(B) ending on November 1 of the</akn:p></akn:content><akn:subsection eId="subsec_1320f_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general The Secretary shall establish a Drug Price Negotiation Program (in this part referred to as the “program”). Under the program, with respect to each price applicability period, the Secretary shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1320f_b"><akn:num>(b)</akn:num><akn:heading>Definitions relating to timing</akn:heading><akn:content><akn:p>(b) Definitions relating to timing For purposes of this part:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1320f_c"><akn:num>(c)</akn:num><akn:heading>Other definitions</akn:heading><akn:content><akn:p>(c) Other definitions For purposes of this part:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1320f_d"><akn:num>(d)</akn:num><akn:heading>Timing for initial price applicability year 2026</akn:heading><akn:content><akn:p>(d) Timing for initial price applicability year 2026 Notwithstanding the provisions of this part, in the case of initial price applicability year 2026, the following rules shall apply for purposes of implementing the program:</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>